Previous studies demonstrated that increased Tp‐Te was associated with mortality in primary percutaneous coronary intervention for myocardial infarction, hypertrophic cardiomyopathy, Brugada syndrome, and long QT syndrome (Haarmark et al., 2009; Shimizu et al., 2002). This evidence concerns the gene TPTE and myocardial infarction.